- Citations, last 5 years
- 44
- Works, last 5 years
- 24
- h-index
- 12
- Scientists listed
- 2
- Grants since 2016
- 5
Grants received
2025–2027 · research · R43
Pharmacokinetics and in vivo efficacy of DA1 macrocyclic peptides in a murine model of Alzheimer's disease
Andrew Loring Schilb · Janus University · funded by National Institutes of Health
2025–2027 · research · R43
In vivo efficacy and in vitro toxicity assessment of peptide-based therapy HV-3 for the Treatment of Huntington's disease
Andrew Loring Schilb · Janus University · funded by National Institutes of Health
2022–2024 · research · R43
Pharmacokinetic and pharmacodynamic assessment of peptide-based therapy DA1 for the treatment of Alzheimer's disease
Andrew Loring Schilb · Janus University · funded by National Institutes of Health
2020–2023 · research · R43
Pharmacokinetic Assessment of Peptide-Based Therapy HV-3 for the Treatment of Huntington's Disease
Andrew Loring Schilb · Janus University · funded by National Institutes of Health
2017–2018 · research · R43
Advanced technology for the improvement of Modular Emergency Radiological Response Transportation Training
Radhakishan Shetty · Janus University · funded by National Institutes of Health
